Literature DB >> 33125934

Who should be prioritised for COVID-19 vaccines?

Zaki Hassan-Smith1, Wasim Hanif2, Kamlesh Khunti3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33125934     DOI： 10.1016/S0140-6736(20)32224-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Understanding COVID-19 Vaccine Hesitancy in Ethnic Minorities Groups in the UK.

Authors:  Maryam Naqvi; Lan Li; Michael Woodrow; Punam Yadav; Patty Kostkova
Journal:  Front Public Health       Date:  2022-07-01

2.  Willingness to receive COVID-19 vaccine and associated factors among adult chronic patients. A cross-sectional study in Northwest Ethiopia.

Authors:  Masresha Derese Tegegne; Surafel Girma; Surafel Mengistu; Tadele Mesfin; Tenanew Adugna; Mehretie Kokeb; Endalkachew Belayneh Melese; Yilkal Belete Worku; Sisay Maru Wubante
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

3.  A conceptual approach to the rationale for SARS-CoV-2 vaccine allocation prioritisation.

Authors:  Malte Kohns Vasconcelos; Chantal Marazia; Markela Koniordou; Heiner Fangerau; Ingo Drexler; Anthony Afum-Adjei Awuah
Journal:  Pathog Glob Health       Date:  2021-06-09       Impact factor: 3.735

Review 4.  Potential SARS-CoV-2 vaccines: Concept, progress, and challenges.

Authors:  Seyede Atefe Hosseini; Fatemeh Zahedipour; Hamed Mirzaei; Reza Kazemi Oskuee
Journal:  Int Immunopharmacol       Date:  2021-03-29       Impact factor: 5.714

5.  SARS-CoV-2 infection: efficacy of extensive vaccination of the healthcare workforce in a large Italian hospital.

Authors:  Maurizio Coggiola; Giuseppe Clemente; Roberto Frammartino; Eugenio Grillo; Alessio Corradi; Michele Corezzi; Omar Kakaa; Ettore Paradisi; Alessandro Tuffanelli; Maria Carolina Alfonso Pensamiento; Alessandro Godono; Enrico Pira
Journal:  Med Lav       Date:  2021-12-23       Impact factor: 1.275

6.  COVID-19: an outbreak in a nursing home in spring 2021.

Authors:  Silvana Castaldi; Stefano Zani; Alessia Lai; Gianguglielmo Zehender; Annalisa Bergna; Catia Rossana Boriello; Danilo Cereda
Journal:  Acta Biomed       Date:  2021-10-07

7.  Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer.

Authors:  Tal Goshen-Lago; Ithai Waldhorn; Roy Holland; Moran Szwarcwort-Cohen; Anat Reiner-Benaim; Yael Shachor-Meyouhas; Khetam Hussein; Liana Fahoum; Mali Baruch; Avivit Peer; Yoram Reiter; Ronit Almog; Michael Halberthal; Irit Ben-Aharon
Journal:  JAMA Oncol       Date:  2021-07-08       Impact factor: 31.777

Review 8.  Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK.

Authors:  Ines Campos-Matos; Sema Mandal; Julie Yates; Mary Ramsay; James Wilson; Wei Shen Lim
Journal:  Lancet Reg Health Eur       Date:  2020-12-23

9.  Comparing COVID-19 risk factors in Brazil using machine learning: the importance of socioeconomic, demographic and structural factors.

Authors:  Pedro Baqui; Valerio Marra; Ahmed M Alaa; Ioana Bica; Ari Ercole; Mihaela van der Schaar
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

10.  Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.

Authors:  Feng Liu; Zebin Zhao; Chunfeng Ma; Xiaowei Nie; Adan Wu; Xin Li
Journal:  Epidemiol Infect       Date:  2022-01-24       Impact factor: 4.434
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.